The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2015

Filed:

Mar. 11, 2013
Applicants:

Evaristus A. Nwulia, Elkridge, MD (US);

Amol Kulkarni, Washington, DC (US);

Inventors:

Evaristus A. Nwulia, Elkridge, MD (US);

Amol Kulkarni, Washington, DC (US);

Assignee:

Howard University, Washington, DC (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/36 (2006.01); A61K 31/40 (2006.01); A61K 31/12 (2006.01); C07C 49/255 (2006.01); C07D 207/36 (2006.01); C07D 307/60 (2006.01); A61K 31/341 (2006.01); C07D 333/32 (2006.01); A61K 31/381 (2006.01); C07C 323/22 (2006.01); A61K 45/06 (2006.01); A61M 31/00 (2006.01); A61K 31/122 (2006.01); A61K 31/4025 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/12 (2013.01); C07C 49/255 (2013.01); C07D 207/36 (2013.01); A61K 31/40 (2013.01); C07D 307/60 (2013.01); A61K 31/341 (2013.01); C07D 333/32 (2013.01); A61K 31/381 (2013.01); C07C 323/22 (2013.01); A61K 45/06 (2013.01); A61M 31/00 (2013.01); A61K 31/122 (2013.01); A61K 31/4025 (2013.01); A61K 9/0043 (2013.01);
Abstract

Compounds having formulas (I) to (VIII), salts thereof, or combinations thereof and pharmaceutical compositions comprising one or more these compounds are described herein for the treatment of HIV and neurodegenerative effects caused by HIV. Also provided herein are methods and a kit for inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia comprising administering the compounds having the formulas (I) to (VIII) and pharmaceutical compositions comprising the compounds having these formulas. The compounds having formulas I through VIII are curcumin analogs which are advantageously characterized as having anti-retroviral, neuroprotective, anti-glucosidase, and anti-HIV integrase properties. In one aspect, the pharmaceutical composition is delivered intranasally.


Find Patent Forward Citations

Loading…